Fulgent Genetics (NASDAQ:FLGT) is preparing to release its quarterly earnings on Friday, 2025-05-02. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...

In “What We Inherit,” Sam Trejo and Daphne O. Martschenko examine the link between genetic myths and social genomics.

Myriad Genetics (NASDAQ:MYGN) has been analyzed by 10 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below provides a snapshot of their ...

Precision medicine -> the practice of treating diseases using insights gained from sequencing the human genome is an increasingly popular term, even in mainstream media. This innovative field offers ...

The race for more data is dominating the wellness industry. More people are tracking their sleep, monitoring their glucose levels, and analyzing their step count as a way to optimize, or even gamify, ...

For more than a century, Mendelian genetics has shaped how we think about inheritance: one gene, one trait. It is a model that still echoes through textbooks—and one that is increasingly reaching its ...